Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Joseph W. Jarabak

TitleEmeritus/Emerita, Associate Professor
InstitutionUniversity of Chicago
DepartmentMedicine
AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Hamm ML, Piccirilli JA. Synthesis and Characterization of Oligonucleotides Containing 2'-S,3'-O-Cyclic Phosphorothiolate Termini. J Org Chem. 1999 Jul 23; 64(15):5700-5704. PMID: 3575753.
      View in: PubMed
    2. Jarabak R, Harvey RG, Jarabak J. Redox cycling of polycyclic aromatic hydrocarbon o-quinones: metal ion-catalyzed oxidation of catechols bypasses inhibition by superoxide dismutase. Chem Biol Interact. 1998 Oct 02; 115(3):201-13. PMID: 9851290.
      View in: PubMed
    3. Jarabak R, Harvey RG, Jarabak J. Redox cycling of polycyclic aromatic hydrocarbon o-quinones: reversal of superoxide dismutase inhibition by ascorbate. Arch Biochem Biophys. 1997 Mar 01; 339(1):92-8. PMID: 9056238.
      View in: PubMed
    4. Jarabak R, Harvey RG, Jarabak J. Polycyclic aromatic hydrocarbon quinone-mediated oxidation reduction cycling catalysed by a human placental 17beta-hydroxysteroid dehydrogenase. Arch Biochem Biophys. 1996 Mar 01; 327(1):174-80. PMID: 8615688.
      View in: PubMed
    5. Jarabak R, Jarabak J. Effect of ascorbate on the DT-diaphorase-mediated redox cycling of 2-methyl-1,4-naphthoquinone. Arch Biochem Biophys. 1995 Apr 20; 318(2):418-23. PMID: 7733672.
      View in: PubMed
    6. Jarabak J, Harvey RG. Studies on three reductases which have polycyclic aromatic hydrocarbon quinones as substrates. Arch Biochem Biophys. 1993 Jun; 303(2):394-401. PMID: 7685581.
      View in: PubMed
    7. Jarabak J. Polycyclic aromatic hydrocarbon quinones may be either substrates for or irreversible inhibitors of the human placental NAD-linked 15-hydroxyprostaglandin dehydrogenase. Arch Biochem Biophys. 1992 Jan; 292(1):239-43. PMID: 1309294.
      View in: PubMed
    8. Jarabak J. Polycyclic aromatic hydrocarbon quinone-mediated oxidation reduction cycling catalyzed by a human placental NADPH-linked carbonyl reductase. Arch Biochem Biophys. 1991 Dec; 291(2):334-8. PMID: 1659323.
      View in: PubMed
    9. Elliott WJ, Murphy MB, Straus FH, Jarabak J. Improved safety of glucagon testing for pheochromocytoma by prior alpha-receptor blockade. A controlled trial in a patient with a mixed ganglioneuroma/pheochromocytoma. Arch Intern Med. 1989 Jan; 149(1):214-6. PMID: 2912409.
      View in: PubMed
    10. Jarabak J, Watkins JD. Purification of the human placental NAD-linked 15-hydroxyprostaglandin dehydrogenase. Prostaglandins. 1988 Aug; 36(2):205-13. PMID: 3187061.
      View in: PubMed
    11. Jarabak J. Inhibition of the human placental NAD- and NADP-linked 15-hydroxyprostaglandin dehydrogenases by nonsteroidal anti-inflammatory drugs. Prostaglandins. 1988 Mar; 35(3):403-11. PMID: 3375453.
      View in: PubMed
    12. Jarabak J, Watkins JD, Lindheimer M. In vitro activity of nicotinamide adenine dinucleotide- and nicotinamide adenine dinucleotide phosphate-linked 15-hydroxyprostaglandin dehydrogenases in placentas from normotensive and preeclamptic/eclamptic pregnancies. J Clin Invest. 1987 Oct; 80(4):936-40. PMID: 3308960.
      View in: PubMed
    13. Chung HS, Harvey RG, Armstrong RN, Jarabak J. Polycyclic aromatic hydrocarbon quinones and glutathione thioethers as substrates and inhibitors of the human placental NADP-linked 15-hydroxyprostaglandin dehydrogenase. J Biol Chem. 1987 Sep 15; 262(26):12448-51. PMID: 3624267.
      View in: PubMed
    14. Chung H, Fried J, Jarabak J. Irreversible inhibition of the human placental NADP-linked 15-hydroxyprostaglandin dehydrogenase/9-ketoprostaglandin reductase by glutathione thiosulfonate. Prostaglandins. 1987 Mar; 33(3):391-402. PMID: 3575754.
      View in: PubMed
    15. Watkins JD, Jarabak J. The effect of NaCl intake on 9-ketoprostaglandin reductase activity in the rabbit kidney. Prostaglandins. 1985 Aug; 30(2):335-49. PMID: 3901124.
      View in: PubMed
    16. Jarabak J, Berkowitz D, Sun FF. Oxidation of prostacyclin and its analogs by three 15-hydroxyprostaglandin dehydrogenases. Prostaglandins. 1984 Oct; 28(4):509-16. PMID: 6441185.
      View in: PubMed
    17. Jarabak J, Luncsford A, Berkowitz D. Substrate specificity of three prostaglandin dehydrogenases. Prostaglandins. 1983 Dec; 26(6):849-68. PMID: 6396732.
      View in: PubMed
    18. Korff JM, Jarabak J. The purification and characterization of a prostacyclin dehydrogenase from rabbit kidney. J Biol Chem. 1982 Mar 10; 257(5):2177-81. PMID: 7061415.
      View in: PubMed
    19. Korff JM, Jarabak J. Isolation and properties of an NADP+-dependent PGI2-specific 15-hydroxyprostaglandin dehydrogenase from rabbit kidney. Methods Enzymol. 1982; 86:152-5. PMID: 6182444.
      View in: PubMed
    20. Jarabak J. Isolation and properties of an NAD+-dependent 15-hydroxyprostaglandin dehydrogenase from human placenta. Methods Enzymol. 1982; 86:126-30. PMID: 7132749.
      View in: PubMed
    21. Jarabak J. Isolation and properties of a 15-ketoprostaglandin delta 13-reductase from human placenta. Methods Enzymol. 1982; 86:163-7. PMID: 7132753.
      View in: PubMed
    22. Feldman R, Luncsford A, Heinrikson RL, Westley J, Jarabak J. Glutathione-related inhibition of prostaglandin metabolism. Arch Biochem Biophys. 1981 Oct 01; 211(1):375-81. PMID: 7305376.
      View in: PubMed
    23. Korff JM, Jarabak J. An NADP-linked prostacyclin dehydrogenase in rabbit kidney. Prostaglandins. 1981 May; 21(5):719-25. PMID: 7041194.
      View in: PubMed
    24. Jarabak J. Early steps in prostaglandin metabolism in the human placenta. Am J Obstet Gynecol. 1980 Nov 01; 138(5):534-40. PMID: 6252782.
      View in: PubMed
    25. Korff J, Jarabak J. Partial isolation and characterization of the 15-hydroxyprostaglandin dehydrogenases and 9-ketoprostaglandin reductases in rabbit kidney. Prostaglandins. 1980 Jul; 20(1):111-25. PMID: 7403570.
      View in: PubMed
    26. Jarabak J, Fried J. Comparison of substrate specificities of the human placental NAD- and NADP-linked 15-hydroxyprostaglandin dehydrogenases. Prostaglandins. 1979 Aug; 18(2):241-6. PMID: 42948.
      View in: PubMed
    27. Lin YM, Jarabak J. Isolation of two proteins with 9-ketoprostaglandin reductase and NADP-linked 15-hydroxyprostaglandin dehydrogenase activities and studies on their inhibition. Biochem Biophys Res Commun. 1978 Apr 28; 81(4):1227-34. PMID: 666816.
      View in: PubMed
    28. Westbrook C, Jarabak J. 15-ketoprostaglandin delta13 reductase from human placenta: purification, kinetics, and inhibitor binding. Arch Biochem Biophys. 1978 Jan 30; 185(2):429-42. PMID: 204253.
      View in: PubMed
    29. Westbrook C, Lin YM, Jarabak J. NADP-linked 15-hydroxyprostaglandin dehydrogenase from human placenta: partial purification and characterization of the enzyme and identification of an inhibitor in placental tissue. Biochem Biophys Res Commun. 1977 Jun 06; 76(3):943-9. PMID: 20082.
      View in: PubMed
    30. Jarabak J, Braithwaite SS. Kinetic studies on a 15-hydroxyprostaglandin dehydrogenase from human placenta. Arch Biochem Biophys. 1976 Nov; 177(1):245-54. PMID: 187123.
      View in: PubMed
    31. Westbrook C, Jarabak J. Purification and partial characterization of an NADH-linked delta13-15-ketoprostaglandin reductase from human placenta. Biochem Biophys Res Commun. 1975 Sep 16; 66(2):541-6. PMID: 241339.
      View in: PubMed
    32. Braithwaite SS, Jarabak J. Studies on a 15-hydroxyprostaglandin dehydrogenase from human placenta. Purification and partial characterization. J Biol Chem. 1975 Mar 25; 250(6):2315-8. PMID: 1117007.
      View in: PubMed
    33. Jarabak J. Human placental 15-hydroxyprostaglandin dehydrogenase. Proc Natl Acad Sci U S A. 1972 Mar; 69(3):533-4. PMID: 4501572.
      View in: PubMed
    34. Jarabak J, Street MA. The inhibition of the soluble human placental 17-beta-hydroxysteroid dehydrogenase by o,p -DDD and its analogs. Endocrinology. 1971 Dec; 89(6):1407-11. PMID: 4330530.
      View in: PubMed
    35. Jarabak J, Street MA. Studies on the soluble 17 -hydroxysteroid dehydrogenase from human placenta. Evidence for a subunit structure. Biochemistry. 1971 Oct 12; 10(21):3831-5. PMID: 5160411.
      View in: PubMed
    36. Jarabak J, Bachur NR. A soluble dihydrofolate reductase from human placenta: purification and properties. Arch Biochem Biophys. 1971 Feb; 142(2):417-25. PMID: 4396284.
      View in: PubMed
    37. Jarabak J, Sack GH. A souble 17 beta-hydroxysteroid dehydrogenase from human placenta. The binding of pyridine nucleotides and steroids. Biochemistry. 1969 May; 8(5):2203-12. PMID: 4389089.
      View in: PubMed
    38. ADAMS JA, JARABAK J, TALALAY P. The steroid specificity of the 17beta-hydroxysteroid dehydrogenase of human placenta. J Biol Chem. 1962 Oct; 237:3069-73. PMID: 14010985.
      View in: PubMed
    39. JARABAK J, ADAMS JA, WILLIAMS-ASHMAN HG, TALALAY P. Purification of a 17beta-hydroxysteroid dehydrogenase of human placenta and studies on its transhydrogenase function. J Biol Chem. 1962 Feb; 237:345-57. PMID: 14451294.
      View in: PubMed
    Jarabak's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (156) concept(s)
    _
    Co-Authors Expand Description
    See all (2) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department
    Physical Neighbors Expand Description
    _